April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Optical Coherence Tomography and Visual Acuity Outcomes After Surgery in Patients With Vitreofoveal Traction Syndrome
Author Affiliations & Notes
  • R. P. Davis, II
    Bascom Palmer Eye Institute, Univ of Miami Miller Sch of Med, Miami, Florida
  • W. E. Smiddy
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • H. W. Flynn, Jr.
    Bascom Palmer Eye Inst, University of Miami, Miami, Florida
  • C. A. Puliafito
    Office of the Dean, Keck School of Medicine of USC, Los Angeles, California
  • Footnotes
    Commercial Relationships  R.P. Davis, II, None; W.E. Smiddy, None; H.W. Flynn, Jr., None; C.A. Puliafito, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2573. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. P. Davis, II, W. E. Smiddy, H. W. Flynn, Jr., C. A. Puliafito; Optical Coherence Tomography and Visual Acuity Outcomes After Surgery in Patients With Vitreofoveal Traction Syndrome. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2573.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To characterize patients with symptomatic visual changes from the vitreofoveal traction syndrome (VFTS) and to report clinical and optical coherence tomography (OCT) features after surgery.

Methods: : A retrospective, non-comparative, interventional case series. 36 consecutive patients were identified by OCT to have focal vitreofoveal traction and underwent pars plana vitrectomy (PPV). All patients had ≥3 months postoperative follow-up examination information.

Results: : All eyes had focal vitreofoveal traction and cystoid macular edema (CME) on OCT. The preoperative best corrected visual acuity (BCVA) ranged from 20/40 to 20/400. 10 (28%) eyes had subfoveal fluid. Vitreofoveal traction was relieved postoperatively in all 29 eyes in which a postoperative OCT was available. The CME markedly or mostly resolved in 25 (86%) eyes, and subretinal fluid resolved or decreased markedly in 8 (89%) eyes. The mean postoperative follow-up interval was 7.3 months. Postoperative BCVA ranged from 20/20 to 1/200 with 12 (33%) eyes remaining within one line of preoperative BCVA, 18 (50%) eyes improving ≥2 lines (11 (31%) of which gained ≥4 lines), and 6 (17%) eyes decreasing ≥2 lines. Patients with <6 month preoperative duration of symptoms were statistically more likely to attain a visual acuity of ≥20/40 postoperatively, with 14/26 (54%) of eyes with symptoms ≤ than 6 months having ≥20/40 BCVA and 1/10 (10%) of eyes with a duration of symptoms > 6 months having a BCVA of ≥ 20/40 (p=0.048).

Conclusions: : Patients with OCT-confirmed VFTS usually achieve favorable visual and anatomic outcomes after pars plana vitrectomy. Rates of visual acuity > 20/40 were higher among patients with less than a 6 month duration of symptoms.

Keywords: vitreoretinal surgery • vitreous • macula/fovea 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.